The approval, given to a licensed version of the drug made by the Serum Institute of India (SII) and exported to dozens of countries, could help health authorities minimise vaccine wastage and better plan their inoculation programmes.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3m2HN4u
via IFTTT
0 comments:
Post a Comment